AMRI Licenses CRISPR-CAS9 Gene Editing Technology
By

By
AMRI, a contract research and manufacturing organization, has entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene-editing technology…

BioInvent Extends Manufacturing Services Contract
By

By
BioInvent International, a Lund, Sweden-based pharmaceutical company focused on antibody-based anti-cancer drugs, has extended its contract for manufacturing services with a major global pharmaceutical client. The extension covers services for…

Metrics Contract Services Invests In Storage Facility
By

By
Metrics Contract Services, a Greenville, North Carolina-based pharmaceutical development and manufacturing organization, is investing $3.5 million in a 15,000-square-foot stability storage expansion that will triple its current capacity. The investment…

Recipharm Increases Lyophilization Capacity In Italy
By

By
Recipharm, a contract development and manufacturing organization, has invested EUR 3.7 million ($4.1 million) to expand its lyophilization capacity at its site in Masate, Italy. This investment is in addition…

Austin Chemical, Syncom, and ChemConnection Form SynConnection JV
By

By
Austin Chemical Company, a Buffalo Grove, Illinois-based pharmaceutical procurement and logistics service provider, has formed a joint venture with Syncom BV, a Groningen, Netherlands-based pharmaceutical contract synthesis company, and ChemConnection…

Regis Technologies Passes FDA Audit
By

By
Regis Technologies, a Morton Grove, Illinois-based contract manufacturing organization, has passed a recent US Food and Drug Administration (FDA) inspection at its active pharmaceutical ingredient (API) facility as it earned…

Ã…F Wins Contract To Upgrade Chr. Hansen’s Denmark Plant
By

By
Ã…F, an engineering and consulting company for the energy, industrial, and infrastructure markets, has signed a new contract with Chr. Hansen, a bioscience company, worth about EUR 5.5 million ($6.2…

Takeda Launches New Access to Medicines Strategy
By

By
Takeda Pharmaceutical Company has launched a new access to medicines (AtM) strategy aimed at increasing access to its medicines to patients with high unmet medical needs. The company has provided…

Leap Therapeutics, Macrocure Agree To Merge
By

By
Leap Therapeutics, a Cambridge, Massachusetts-based clinical-stage immuno-oncology company, has agreed to merge with Macrocure, a Petach Tikva, Israel-based clinical-stage biopharmaceutical company focused on chronic and hard-to-heal wounds. Under the agreement,…

Ferring Acquires Exclusive Rights To Seikagaku’s Injection Drug
By

By
Ferring Pharmaceuticals, a biopharmaceutical company based in Saint-Prex, Switzerland, has acquired exclusive development and commercialization rights to condoliase, a potential injection treatment for lumbar disc herniation by Seikagaku Corporation, a…